Oncternal Therapeutics Inc. Stock

Oncternal Therapeutics Inc. took a tumble today and lost -€0.550 (-8.410%).
Based on 2 Buy predictions and 2 Sell predictions the sentiment towards Oncternal Therapeutics Inc. is rather balanced.
This results in a negative potential of -38.776% based on a current price of €4.90 and a target price of €3.00 for the stock.
For the coming years our community has positive and negative things to say abot the Oncternal Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.